Nav1.8 (encoded by the SCN10A gene) is a voltage-gated sodium channel predominantly expressed in peripheral sensory neurons, where it plays a crucial role in pain signal transmission. As one of the tetrodotoxin-resistant (TTX-R) sodium channels, Nav1.8 exhibits unique electrophysiological properties that enable it to sustain repetitive firing in nociceptive neurons and contribute to the generation and propagation of pain signals. The channel's restricted expression pattern makes it an attractive target for pain therapeutics, with efforts focused on developing selective inhibitors that can treat chronic pain conditions without affecting central nervous system function [chatterjee2012].
Voltage-gated sodium channels are membrane proteins that allow the rapid influx of sodium ions during the upstroke of action potentials. The Nav1.8 channel belongs to the Nav1 family, which includes nine distinct channel subtypes (Nav1.1-Nav1.9), each with unique expression patterns and functional properties. Unlike the TTX-sensitive channels that are blocked by nanomolar concentrations of tetrodotoxin, Nav1.8 and its close relative Nav1.9 are relatively resistant to TTX, requiring micromolar concentrations for block [dibhajj2009].
Nav1.8 Sodium Channel is a voltage-gated sodium channel specifically expressed in peripheral sensory neurons, particularly in small-diameter C-fiber and Aδ-fiber nociceptors. The channel contributes to the depolarizing phase of action potentials in these neurons and is essential for the transmission of pain signals from the periphery to the central nervous system. Pathological changes in Nav1.8 function are implicated in neuropathic pain, inflammatory pain, and various chronic pain conditions [woolf1999].
The SCN10A gene encodes the Nav1.8 α-subunit, which forms the pore of the channel. This protein consists of four homologous domains (I-IV), each containing six transmembrane segments (S1-S6). The S4 segment serves as the voltage sensor, while the S5-S6 segments form the pore. Associated β-subunits modulate channel trafficking, gating, and expression at the plasma membrane [arimura2004].
Nav1.8 shares the general architecture of voltage-gated sodium channels:
The channel has a relatively depolarized voltage-dependence of activation (around -30 mV) compared to many other sodium channels, allowing it to open at more negative membrane potentials. Its slow inactivation kinetics contribute to its role in sustaining repetitive firing [catterall2012].
Nav1.8 is one of several "tetrodotoxin-resistant" (TTX-R) sodium channels that require much higher concentrations of TTX for block. This resistance is due to structural features in the pore region that prevent TTX binding. The functional significance of TTX resistance is unclear but may relate to the physiological roles of these channels in sensory neurons that must function in varied and sometimes extreme environments [biernat2014].
Nav1.8 supports high-frequency repetitive firing in nociceptive neurons due to:
These properties make Nav1.8 particularly important for the sustained firing required to transmit chronic pain signals [ekberg2006].
Nav1.8 is expressed almost exclusively in peripheral sensory neurons, particularly:
Within these neurons, Nav1.8 is localized primarily to the cell body (soma) and along the axons, where it contributes to action potential initiation and propagation [waxman2014].
The cell bodies of sensory neurons are located in the dorsal root ganglion (DRG) and trigeminal ganglion. Nav1.8 is highly expressed in:
The expression pattern is species-dependent and can be altered by nerve injury or inflammation [sheet2008].
Following nerve injury or inflammation, Nav1.8 expression can increase significantly:
This upregulation is a key mechanism underlying the transition from acute to chronic pain [abbadie2009].
Nav1.8 contributes to nociceptor function in several ways:
The channel is particularly important for the sustained, repetitive firing that characterizes chronic pain states [hoyer2008].
Inflammatory mediators sensitize nociceptors partly through Nav1.8:
This sensitization contributes to hyperalgesia (increased pain from normally painful stimuli) and allodynia (pain from normally non-painful stimuli) [obrien2014].
Nerve injury produces long-lasting changes in Nav1.8:
Nav1.8 is a major contributor to neuropathic pain, and blocking the channel can reverse pain behaviors in animal models [raouf2010].
Nav1.8 is expressed in visceral afferents and contributes to:
The visceral pain system shows similar Nav1.8-dependent sensitization to somatic pain pathways [leipzig2012].
Mutations in SCN10A are associated with several pain disorders:
These human mutations confirm the critical role of Nav1.8 in pain signaling [huang2017].
Emerging evidence links Nav1.8 to migraine pathophysiology:
Targeting Nav1.8 may provide a novel approach to migraine treatment [fischer2019].
Neonates and infants express Nav1.8 and are vulnerable to:
Understanding Nav1.8 in neonates is critical for safe analgesic development [embleton2019].
Pharmaceutical companies have pursued selective Nav1.8 blockers:
These compounds aim to provide analgesia without the cardiac and CNS side effects of non-selective sodium channel blockers [yanagisawa2019].
Nav1.8 blockers often exhibit state-dependence:
This property is beneficial for treating chronic pain while minimizing side effects [kingwell2020].
Novel approaches to target Nav1.8 include:
These approaches may provide longer-lasting pain relief than small molecule inhibitors.
Although Nav1.8 is not expressed in the heart, some blockers have cardiovascular effects:
Some Nav1.8 blockers can cross the blood-brain barrier:
Not all pain conditions respond to Nav1.8 blockade: